A homologous stem cell therapy for obesity and its related metabolic disorders

Med Hypotheses. 2017 Jun:103:26-28. doi: 10.1016/j.mehy.2017.03.034. Epub 2017 Apr 4.

Abstract

Obesity and overweight have become a leading health problem in the world. But we have not yet had any optimal therapy to prevent this health issue. Accumulating evidence suggests that there is existence of functional brown/brite adipocytes in both infants and adult humans, and the activated brown/brite can burn energy by generating heat. These adipocytes can be differentiated from stem cells and transplantation of pre-activated human thermogenic adipocytes in vitro benefits to glucose homeostasis, insulin sensitivity and reduces body fat in normal or obese immunodeficient mice. These investigations lead us to hypothesize a homologous stem cell therapy to treat obesity and its related disorders. The therapy bases on functional brown/brite adipocytes which are differentiated from homologous stem cells isolated from fat depot of an obese person, and those adipocytes are activated to have a full thermogenic program before being transplanted back to that patient to improve glucose homeostasis and reduce fat content.

Keywords: Brown/brite adipocytes; Human thermogenic adipocytes; Obesity and overweight; Stem cell therapy.

MeSH terms

  • Adipocytes, Brown / cytology*
  • Adipose Tissue, Brown / pathology
  • Adipose Tissue, White / pathology
  • Animals
  • Body Weight
  • Cell Differentiation
  • Disease Models, Animal
  • Glucose / metabolism
  • Homeostasis
  • Humans
  • Insulin / metabolism
  • Insulin Resistance
  • Metabolic Diseases / therapy*
  • Mice
  • Mice, SCID
  • Obesity / pathology
  • Obesity / therapy*
  • Rats
  • Stem Cell Transplantation / methods*
  • Stem Cells / cytology*
  • Thermogenesis

Substances

  • Insulin
  • Glucose